Proposed Class Action Settlement May Cost Acella $46.5M
A proposed agreement to end a class action over thyroid medication, after a U.S. Food and Drug Administration inspection found products with an active ingredient above and below label specifications, may...To view the full article, register now.
Already a subscriber? Click here to view full article